Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

Oligometastatic disease has been proposed as an intermediate state between localised and systemically metastasised disease. In the absence of randomised phase 3 trials, early clinical studies show improved survival when radical local therapy is added to standard systemic therapy for oligometastatic...

Full description

Saved in:

Bibliographic Details
Published in:	The lancet oncology Vol. 21; no. 1; pp. e18 - e28
Main Authors:	Guckenberger, Matthias, Lievens, Yolande, Bouma, Angelique B, Collette, Laurence, Dekker, Andre, deSouza, Nandita M, Dingemans, Anne-Marie C, Fournier, Beatrice, Hurkmans, Coen, Lecouvet, Frédéric E, Meattini, Icro, Méndez Romero, Alejandra, Ricardi, Umberto, Russell, Nicola S, Schanne, Daniel H, Scorsetti, Marta, Tombal, Bertrand, Verellen, Dirk, Verfaillie, Christine, Ost, Piet
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01.01.2020 Elsevier Limited
Subjects:	Androgens Biomarkers Cancer therapies Classification Clinical medicine Clinical trials Consensus Diagnosis Hematology, Oncology, and Palliative Medicine Humans Literature reviews Lung cancer Medical diagnosis Medical Oncology Metastases Metastasis MicroRNAs Neoplasm Metastasis Neoplasms - classification Neoplasms - pathology Neoplasms - therapy Nomenclature Oncology Patients Practice Guidelines as Topic - standards Prognosis Prostate cancer Radiation therapy Studies Surveillance Systematic review
ISSN:	1470-2045, 1474-5488, 1474-5488
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!